Stryker Corp

詳細情報 Stryker Corp 企業名

Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.

企業情報

企業コードSYK

会社名Stryker Corp

上場日Mar 17, 1980

設立日1946

最高経営責任者「CEO」Mr. Kevin A. Lobo

従業員数53000

証券種類Ordinary Share

決算期末Mar 17

本社所在地1941 Stryker Way

都市PORTAGE

証券取引所NYSE Consolidated

国United States of America

郵便番号49002

電話番号12693852600

ウェブサイトhttps://www.stryker.com/

企業コードSYK

上場日Mar 17, 1980

設立日1946

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Kevin A. Lobo

Chairman of the Board, President, Chief Executive Officer

122.99K

+22.11%

Mr. Spencer S. Stiles

Group President - Orthopaedics and Spine

64.47K

+13.09%

Ms. Ronda E. Stryker

Independent Director

45.90K

+1.24%

Ms. Yin C. Becker

Vice President - Chief Corporate Affairs Officer

33.06K

+2.71%

Mr. Viju S. Menon

Group President - Global Quality and Operations

13.19K

+42.64%

Mr. Robert S. Fletcher

Vice President, Chief Legal Officer

10.38K

+50.92%

Mr. Preston W. Wells

Chief Financial Officer, Vice President

7.25K

--

Ms. Mary K. Brainerd

Independent Director

6.38K

+9.63%

Mr. Rajeev Suri

Independent Director

5.78K

+10.74%

Dr. Giovanni Caforio, M.D.

Independent Director

2.80K

+25.01%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Kevin A. Lobo

Chairman of the Board, President, Chief Executive Officer

122.99K

+22.11%

Mr. Spencer S. Stiles

Group President - Orthopaedics and Spine

64.47K

+13.09%

Ms. Ronda E. Stryker

Independent Director

45.90K

+1.24%

Ms. Yin C. Becker

Vice President - Chief Corporate Affairs Officer

33.06K

+2.71%

Mr. Viju S. Menon

Group President - Global Quality and Operations

13.19K

+42.64%

Mr. Robert S. Fletcher

Vice President, Chief Legal Officer

10.38K

+50.92%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Medical

3.85B

17.05%

Trauma and Extremities

3.51B

15.52%

Endoscopy

3.39B

15.00%

Instruments

2.83B

12.54%

Knees

2.45B

10.83%

Other

6.57B

29.06%

地域別USD

会社名

収益

比率

United States

16.94B

74.99%

Europe & Middle East & Africa (EMEA) (Region)

2.90B

12.82%

Asia Pacific (Region)

2.02B

8.94%

Other countries

735.00M

3.25%

事業別

地域別

事業別USD

会社名

収益

比率

Medical

3.85B

17.05%

Trauma and Extremities

3.51B

15.52%

Endoscopy

3.39B

15.00%

Instruments

2.83B

12.54%

Knees

2.45B

10.83%

Other

6.57B

29.06%

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

8.61%

Brown (John W)

5.25%

Greenleaf Trust

4.48%

BlackRock Institutional Trust Company, N.A.

4.34%

State Street Global Advisors (US)

3.87%

Other

73.45%

株主統計

比率

The Vanguard Group, Inc.

8.61%

Brown (John W)

5.25%

Greenleaf Trust

4.48%

BlackRock Institutional Trust Company, N.A.

4.34%

State Street Global Advisors (US)

3.87%

Other

73.45%

種類

株主統計

比率

Investment Advisor

36.93%

Investment Advisor/Hedge Fund

29.60%

Bank and Trust

6.67%

Individual Investor

5.36%

Research Firm

3.26%

Pension Fund

2.04%

Sovereign Wealth Fund

1.33%

Hedge Fund

0.82%

Family Office

0.13%

Other

13.86%

機関投資家保有株

更新時刻: Thu, Feb 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

3406

327.17M

85.61%

-3.69M

2024Q4

3392

326.31M

85.52%

-6.25M

2024Q3

3219

327.28M

85.85%

-2.63M

2024Q2

3172

322.05M

84.52%

-4.86M

2024Q1

3130

320.11M

84.03%

-8.55M

2023Q4

3047

327.61M

86.24%

+19.84M

2023Q3

2938

324.92M

85.54%

+14.80M

2023Q2

2898

325.04M

85.60%

+10.05M

2023Q1

2838

330.33M

87.03%

+17.40M

2022Q4

2800

311.07M

82.21%

-3.07M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

32.55M

8.53%

+257.04K

+0.80%

Dec 31, 2024

Brown (John W)

20.06M

5.25%

--

Feb 28, 2025

Greenleaf Trust

17.39M

4.56%

-355.66K

-2.00%

Feb 28, 2025

BlackRock Institutional Trust Company, N.A.

16.58M

4.34%

-688.56K

-3.99%

Dec 31, 2024

State Street Global Advisors (US)

14.78M

3.87%

+196.16K

+1.35%

Dec 31, 2024

T. Rowe Price Associates, Inc.

10.61M

2.78%

+48.98K

+0.46%

Dec 31, 2024

JP Morgan Asset Management

6.80M

1.78%

-146.43K

-2.11%

Dec 31, 2024

Geode Capital Management, L.L.C.

7.07M

1.85%

+168.44K

+2.44%

Dec 31, 2024

Fidelity Management & Research Company LLC

7.37M

1.93%

+749.68K

+11.32%

Dec 31, 2024

Capital Research Global Investors

6.84M

1.79%

-210.56K

-2.99%

Dec 31, 2024

詳細を見る

関連ETF

更新時刻: Fri, Jun 6

銘柄名

比率

Jensen Quality Growth ETF

6.69%

Parnassus Core Select ETF

5.98%

iShares U.S. Medical Devices ETF

4.7%

Gabelli Growth Innovators ETF

4.14%

AdvisorShares Focused Equity ETF

4.06%

JPMorgan Healthcare Leaders ETF

3.67%

Democratic Large Cap Core ETF

3.59%

Global X Aging Population ETF

3.05%

AdvisorShares Gerber Kawasaki ETF

2.94%

Tema Neuroscience and Mental Health ETF

2.94%

詳細を見る

Jensen Quality Growth ETF

比率6.69%

Parnassus Core Select ETF

比率5.98%

iShares U.S. Medical Devices ETF

比率4.7%

Gabelli Growth Innovators ETF

比率4.14%

AdvisorShares Focused Equity ETF

比率4.06%

JPMorgan Healthcare Leaders ETF

比率3.67%

Democratic Large Cap Core ETF

比率3.59%

Global X Aging Population ETF

比率3.05%

AdvisorShares Gerber Kawasaki ETF

比率2.94%

Tema Neuroscience and Mental Health ETF

比率2.94%

配当金

過去5年間の配当金総支払額は 5.22B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Dec 10, 2024

SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024

Dec 31, 2024

Jan 31, 2025

Dec 31, 2024

Aug 07, 2024

SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024

Sep 30, 2024

Oct 31, 2024

Sep 30, 2024

May 09, 2024

SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024

Jun 28, 2024

Jul 31, 2024

Jun 28, 2024

Feb 07, 2024

SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024

Mar 29, 2024

Apr 30, 2024

Mar 27, 2024

Dec 05, 2023

SYK.NB Final Cash Dividend of gross USD 0.8 paid on Jan 31, 2024 going ex on Dec 28, 2023

Dec 29, 2023

Jan 31, 2024

Dec 28, 2023

Aug 02, 2023

SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Oct 31, 2023 going ex on Sep 28, 2023

Sep 29, 2023

Oct 31, 2023

Sep 28, 2023

May 10, 2023

SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 31, 2023 going ex on Jun 29, 2023

Jun 30, 2023

Jul 31, 2023

Jun 29, 2023

Feb 09, 2023

SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 28, 2023 going ex on Mar 30, 2023

Mar 31, 2023

Apr 28, 2023

Mar 30, 2023

Dec 07, 2022

SYK.NB Final Cash Dividend of gross USD 0.75 paid on Jan 31, 2023 going ex on Dec 29, 2022

Dec 30, 2022

Jan 31, 2023

Dec 29, 2022

Aug 03, 2022

SYK.NB Interim Cash Dividend of gross USD 0.695 paid on Oct 31, 2022 going ex on Sep 29, 2022

Sep 30, 2022

Oct 31, 2022

Sep 29, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

392.230USD

Stryker Corp

392.230

概要

企業名